BioSpace News Archive

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will be kicking off the new year by attending the J.P. Morgan Healthcare and Biotech Showcase Conferences in San Francisco.

A year after Color and NorthShore University HealthSystem (NorthShore) announced their partnership to integrate clinical genomics into routine primary care, the two organizations have completed the largest U.S. genomics program to date.

This order by the U.S. Supreme Court ensures that the ‘610 patent will remain exclusive at least through November 2, 2027, absent further challenges from other parties.

PhaseBio to be responsible for all development, manufacturing and commercialization

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Wednesday, January 29, 2020.

U.S. District Judge Sean F. Cox entered a consent decree of permanent injunction between the U.S. and Home Style Foods, Inc., and the company’s owner, Michael J. Kowalski, and quality manager, Juan Valesquez. Home Style Foods, Inc., a Michigan-based food manufacturer, has agreed to discontinue selling food products until the company complies with federal regulations and other requirements.

Following discussions with the Company, the ANSM decision to allow new patient recruitment to resume in Sézary syndrome and MF in France is based on an assessment of the unmet medical need and the lack of currently available standard of care options.

Proton Therapy Partners and CHAMPS Oncology are collaborating to create customized cancer data reports through CHAMPS’ insight2oncology® system.

Leidos will enable its customers to deliver Clarify-generated observed and predictive insights directly into healthcare operations through its careC2 platform.

Helix BioPharma Corp. announced it has closed a private placement financing of 2,940,000 units of the Company and the disposition of shares of the Company’s Polish subsidiary, Helix Immuno-Oncology S.A., representing an 8.5% stake in HIO for aggregate gross proceeds of approximately CAD $3,000,000, or $1.02 per Purchased Security.